Purchases and Sales Made in Q1 2023 in Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT) during Q1 2023. The information is specifically focused on institutions that hold shares of Nuvectis Pharma, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
24.7KNew |
$181K - $354K
|
24.7K
$116K
|
|
May 11, 2023
Q1 2023
|
Edmond De Rothschild Holding S.A.
Chambesy, V8 |
BUY
|
- |
24.6KNew |
$180K - $353K
|
24.6K
$115K
|
|
May 15, 2023
Q1 2023
|
Man Group PLC
London, X0 |
BUY
|
- |
12.8KNew |
$94K - $185K
|
12.8K
$60.3K
|
|
May 15, 2023
Q1 2023
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
11.1KNew |
$81.1K - $159K
|
11.1K
$52.1K
|
|
Apr 21, 2023
Q1 2023
|
Baldwin Brothers LLC
|
BUY
|
- |
10.5K+ 7.88% |
$76.9K - $151K
|
144K
$676K
|
|
May 15, 2023
Q1 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
5.6K+ 2.86% |
$41K - $80.5K
|
201K
$947K
|
|
May 15, 2023
Q1 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
3.65K+ 11.65% |
$26.7K - $52.5K
|
35K
$165K
|
|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
3.4K+ 33.41% |
$24.9K - $48.8K
|
13.6K
$63.7K
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
2.81K+ 934.88% |
$20.6K - $40.4K
|
3.12K
$14.6K
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
BUY
|
- |
1.7K+ 14.53% |
$12.4K - $24.4K
|
13.4K
$63K
|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
152+ 1266.67% |
$1.11K - $2.18K
|
164
$771
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.11K- 81.6% |
$8.12K - $15.9K
|
250
$1.18K
|